NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma

Abstract Multiple myeloma (MM) remains an incurable plasma cell cancer characterized by abnormal secretion of monoclonal immunoglobulins. The molecular mechanism that regulates the drug sensitivity of MM cells is being intensively studied. Here, we report an unexpected finding that the protein encod...

Full description

Bibliographic Details
Main Authors: Xi Huang, Wen Cao, Shunnan Yao, Jing Chen, Yang Liu, Jianwei Qu, Yi Li, Xiaoyan Han, Jingsong He, He Huang, Enfan Zhang, Zhen Cai
Format: Article
Language:English
Published: Nature Publishing Group 2022-03-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-022-04629-8
_version_ 1818919685516689408
author Xi Huang
Wen Cao
Shunnan Yao
Jing Chen
Yang Liu
Jianwei Qu
Yi Li
Xiaoyan Han
Jingsong He
He Huang
Enfan Zhang
Zhen Cai
author_facet Xi Huang
Wen Cao
Shunnan Yao
Jing Chen
Yang Liu
Jianwei Qu
Yi Li
Xiaoyan Han
Jingsong He
He Huang
Enfan Zhang
Zhen Cai
author_sort Xi Huang
collection DOAJ
description Abstract Multiple myeloma (MM) remains an incurable plasma cell cancer characterized by abnormal secretion of monoclonal immunoglobulins. The molecular mechanism that regulates the drug sensitivity of MM cells is being intensively studied. Here, we report an unexpected finding that the protein encoded by neural precursor cell-expressed developmentally downregulated gene 4L (NEDD4L), which is a HECT E3 ligase, binds the 19S proteasome, limiting its proteolytic function and enhancing autophagy. Suppression of NEDD4L expression reduced bortezomib (Bor) sensitivity in vitro and in vivo, mainly through autophagy inhibition mediated by low NEDD4L expression, which was rescued by an autophagy activator. Clinically, elevated expression of NEDD4L is associated with a considerably increased probability of responding to Bor, a prolonged response duration, and improved overall prognosis, supporting both the use of NEDD4L as a biomarker to identify patients most likely to benefit from Bor and the regulation of NEDD4L as a new approach in myeloma therapy.
first_indexed 2024-12-20T01:09:47Z
format Article
id doaj.art-ecd6f5cc86e54cb79176915776c694b1
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-12-20T01:09:47Z
publishDate 2022-03-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-ecd6f5cc86e54cb79176915776c694b12022-12-21T19:58:44ZengNature Publishing GroupCell Death and Disease2041-48892022-03-0113311210.1038/s41419-022-04629-8NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myelomaXi Huang0Wen Cao1Shunnan Yao2Jing Chen3Yang Liu4Jianwei Qu5Yi Li6Xiaoyan Han7Jingsong He8He Huang9Enfan Zhang10Zhen Cai11Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang UniversityBone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang UniversityBone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang UniversityBone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang UniversityBone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang UniversityBone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang UniversityBone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang UniversityBone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang UniversityBone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang UniversityBone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang UniversityBone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang UniversityBone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang UniversityAbstract Multiple myeloma (MM) remains an incurable plasma cell cancer characterized by abnormal secretion of monoclonal immunoglobulins. The molecular mechanism that regulates the drug sensitivity of MM cells is being intensively studied. Here, we report an unexpected finding that the protein encoded by neural precursor cell-expressed developmentally downregulated gene 4L (NEDD4L), which is a HECT E3 ligase, binds the 19S proteasome, limiting its proteolytic function and enhancing autophagy. Suppression of NEDD4L expression reduced bortezomib (Bor) sensitivity in vitro and in vivo, mainly through autophagy inhibition mediated by low NEDD4L expression, which was rescued by an autophagy activator. Clinically, elevated expression of NEDD4L is associated with a considerably increased probability of responding to Bor, a prolonged response duration, and improved overall prognosis, supporting both the use of NEDD4L as a biomarker to identify patients most likely to benefit from Bor and the regulation of NEDD4L as a new approach in myeloma therapy.https://doi.org/10.1038/s41419-022-04629-8
spellingShingle Xi Huang
Wen Cao
Shunnan Yao
Jing Chen
Yang Liu
Jianwei Qu
Yi Li
Xiaoyan Han
Jingsong He
He Huang
Enfan Zhang
Zhen Cai
NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma
Cell Death and Disease
title NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma
title_full NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma
title_fullStr NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma
title_full_unstemmed NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma
title_short NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma
title_sort nedd4l binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma
url https://doi.org/10.1038/s41419-022-04629-8
work_keys_str_mv AT xihuang nedd4lbindstheproteasomeandpromotesautophagyandbortezomibsensitivityinmultiplemyeloma
AT wencao nedd4lbindstheproteasomeandpromotesautophagyandbortezomibsensitivityinmultiplemyeloma
AT shunnanyao nedd4lbindstheproteasomeandpromotesautophagyandbortezomibsensitivityinmultiplemyeloma
AT jingchen nedd4lbindstheproteasomeandpromotesautophagyandbortezomibsensitivityinmultiplemyeloma
AT yangliu nedd4lbindstheproteasomeandpromotesautophagyandbortezomibsensitivityinmultiplemyeloma
AT jianweiqu nedd4lbindstheproteasomeandpromotesautophagyandbortezomibsensitivityinmultiplemyeloma
AT yili nedd4lbindstheproteasomeandpromotesautophagyandbortezomibsensitivityinmultiplemyeloma
AT xiaoyanhan nedd4lbindstheproteasomeandpromotesautophagyandbortezomibsensitivityinmultiplemyeloma
AT jingsonghe nedd4lbindstheproteasomeandpromotesautophagyandbortezomibsensitivityinmultiplemyeloma
AT hehuang nedd4lbindstheproteasomeandpromotesautophagyandbortezomibsensitivityinmultiplemyeloma
AT enfanzhang nedd4lbindstheproteasomeandpromotesautophagyandbortezomibsensitivityinmultiplemyeloma
AT zhencai nedd4lbindstheproteasomeandpromotesautophagyandbortezomibsensitivityinmultiplemyeloma